Key result
Accounting for triglyceride measurement uncertainty lowers the Friedewald equation threshold to /dL.
Why the study?
The Friedewald equation for LDL-C estimation loses reliability near the 400 mg/dL (4.5 mmol/L) triglyceride threshold, and whether this conventional threshold remains analytically appropriate when accounting for measurement uncertainty was unclear.
Does incorporating measurement uncertainty into the Friedewald equation alter the upper triglyceride threshold for reliable LDL-C calculation in routine clinical laboratory lipid panels?
Observational (n=122,639)
No
Does incorporating measurement uncertainty into the Friedewald equation alter the upper triglyceride threshold for reliable LDL-C calculation in routine clinical laboratory lipid panels?
Incorporating analytical measurement uncertainty lowers the upper triglyceride limit for reliable Friedewald LDL-C calculation from 400 mg/dL to 369 mg/dL, preventing potential LDL-C misclassification in 0.7% of routine patients.
Answers are grounded in this paper and cite their sources.
Suggests caution with Friedewald LDL-C estimates as triglycerides approach 400 mg/dL; leaves open whether laboratory-specific uncertainty cutoffs improve clinical risk classification over alternative equations.
BACKGROUND: Accurate estimation of LDL cholesterol (LDL-C) is essential for cardiovascular risk assessment and treatment. The widely-used Friedewald equation loses reliability at higher triglyceride (TG) levels, particularly near the 400 mg/dL (4.5 mmol/L) threshold. This study aimed to evaluate the measurement uncertainty (MU) of TG, total cholesterol (CHOL), HDL cholesterol (HDL-C), directly-measured LDL-C, and Friedewald-calculated LDL-C using the Nordtest guideline and aimed to determine whether the conventional TG threshold remains analytically appropriate when MU is considered. METHODS: We retrospectively analyzed 12-month internal quality control (IQC) and external quality assessment (EQA) data from the lipid panel performed in a single-center laboratory using the Mindray BS-2000M analyzer. Combined and expanded MU values were calculated for each analyte and compared to maximum allowable uncertainty (MAU) targets. The impact of TG MU on the Friedewald equation's TG threshold was assessed using routine patient data from February 2024 through January 2025. RESULTS: MU values for TG (8.4%) and direct LDL-C (6.2%) were within their MAU targets, while those for HDL-C (8.7%) and CHOL (7.7%) exceeded their respective thresholds. The calculated LDL-C showed a higher MU (13.3%), largely influenced by TG and HDL-C variability. Based on the 8.4% MU of TG, a revised upper threshold of 369 mg/dL (4.2 mmol/L) was proposed. Out of 122,639 patient results, 848 (0.7%) had TG levels between 369 - 400 mg/dL, indicating potential LDL-C misclassification. CONCLUSIONS: Measurement uncertainty substantially impacts the reliability of calculated LDL-C near the TG threshold. Clinical laboratories should consider incorporating MU into LDL-C interpretation and re-evaluating TG limits to improve risk stratification and treatment accuracy.
No takes yet. Share an insight, caveat, or question.
Çat et al. (2026) conducted an observational in Lipid profiling for LDL-C calculation (n=122,639). Incorporation of measurement uncertainty (MU) into the Friedewald equation TG threshold vs. Conventional TG threshold of 400 mg/dL (4.5 mmol/L) was evaluated on Expanded measurement uncertainty (MU) of Friedewald-calculated LDL-C and revised TG threshold for potential LDL-C misclassification. Accounting for an 8.4% triglyceride measurement uncertainty lowers the Friedewald equation TG threshold to /dL, identifying 848 of 122,639 results at risk of LDL-C misclassification.
Synapse has enriched 10 related papers. Consider them for comparative context: